跳至主要内容
临床试验/DRKS00024428
DRKS00024428招募中不适用

Myasthenia gravis: diagnostic, prognostic, and treatment response markers - Myasthenie-Kohorte

Klinik für NeurologieNeuroCure Clinical Research Center (NCRC)Charité Universitätsmedizin BerlinCharité Campus Mitte0 个研究点目标入组 1,600 人开始时间: 2021年2月10日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Inclusion criteria Myasthenia patients:
  • - Confirmed diagnosis of myasthenia gravis.
  • - Men and women
  • - Ability to give consent
  • - Written informed consent
  • Inclusion criteria Controls:
  • - Men and women
  • - Capacity to consent
  • - Written informed consent
  • Group 1: age-matched, no neurological diseases with motor impairments, no autoimmunological diseases, no depression.
  • Group 2: age-matched, other neuroimmunological diseases (e.g. multiple sclerosis, immune neuropathies)

排除标准

  • General Exclusion Criteria:
  • - Lack of communication skills
  • - Alcohol or drug abuse (current)

研究者

发起方
Klinik für NeurologieNeuroCure Clinical Research Center (NCRC)Charité Universitätsmedizin BerlinCharité Campus Mitte

相似试验